A key trend seen in 2024 and recent years is the simplification of basket sizes, as countries look to streamline and simplify.

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Eric Karas, Chief Commercial Officer, outlined the company's multi-pronged strategy to increase neffy adoption, focusing on education, payer coverage, and patient awareness. He noted that neffy ...

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 26,020.89 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...